Virtu Financial’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,708	Closed	-$350K	–	1604
2023 Q2	$350K	Buy	+8,708	New	+$350K	0.03%	544
2021 Q3	–	Sell	-5,144	Closed	-$218K	–	1736
2021 Q2	$218K	Buy	+5,144	New	+$218K	0.02%	940